Key Questions Answered
- Where does ultrasound AI value sit beyond the recurring software line?
- Which use cases are ready for scaled monetization, and which still need evidence?
- How do per-study, subscription, bundle and hybrid usage contracts compare on observed economics?
- What did the 2025-2026 coding and payment changes alter?
Market Snapshot
The report separates core AI recurring revenue, which sits inside ecosystem totals, from a broader AI value-pool bridge spanning hardware-linked AI, software, services and cloud or pay-per-use. The widening gap between them is value that transacts through bundles, upgrades and consumption. Cloud and pay-per-use grows fastest; software stays largest. North America anchors monetization quality, while China offers deployment scale with thinner recurring economics.Key Market Trends
1. Value is migrating above the probe. The console becomes the platform for selling guidance, reporting automation and cloud review.2. Reimbursement sets the price ceiling. The same capability prices near zero without a code and at a premium with one.
3. Payment moved from thesis to fact. First echo-AI payments and the first AI code family in CPT 2026 set public prices.
4. Case-finding outsells efficiency. Detecting missed, billable disease builds a more durable purchase case than productivity alone.
5. Embedding versus vendor-agnostic insertion is the structural fork. Feature-only vendors without a code or channel face absorption.
Competitive Structure
Competition is analyzed as five sub-battlegrounds, from guided acquisition to cloud review. The report maps control points, dates OEM moves by GE HealthCare, Philips, Samsung Medison and Siemens Healthineers, and profiles twelve vendors including Ultromics, UltraSight, Butterfly Network, Echo IQ and Koios Medical.What's Inside
Revenue architecture: AI streams, capabilities, hardware segments and regions, with US and China views.Markintel® frameworks: Solution Adoption & Growth Matrix, ARC-Index readiness scoring and the Upgrade & Package Ladder.
Pricing and reimbursement: Five commercial archetypes, an observed price ladder and four US payment pathways ranked by durability.
Playbooks and signposts: Six player-specific playbooks and dated signals for the next 12-24 months.
Who Should Read This Report
- Ultrasound OEM and handheld platform executives
- AI software founders and product leaders
- Workflow, reporting and enterprise imaging vendors
- Health systems and POCUS programs buying at fleet scale
- Investors and corporate-development teams
Why This Report
This report follows the money. It ties each use case to a buyer, contract form, ROI logic and reimbursement rung, and keeps every modeled figure traceable to one core model, showing which capabilities can carry scaled economics.Companies Mentioned
- Abbott
- Aidoc
- AISAP
- Artrya
- AS Software
- Biotics AI
- BrightHeart
- Butterfly Network
- Canon Medical
- Caption Health
- Clarius
- Cleerly
- ContextVision
- Deep Breathe
- DiA Imaging Analysis
- Diagnoly
- DolphinSonic
- Echo IQ
- EchoNous
- Edwards Lifesciences
- Eko Health
- ESI
- Exo
- FUJIFILM Sonosite
- GE HealthCare
- Harrison.ai
- HeartFlow
- HeartFocus/DESKi
- HeartLab
- Intelligent Ultrasound/Surgical Science
- Koios Medical
- MediReport
- Mindray
- MyCardium AI
- NerveBlox
- NVIDIA
- Philips
- PIUR Imaging
- Pulsenmore
- Qure.ai
- RadNet/DeepHealth
- Samsung Medison
- See-Mode
- Siemens Healthineers
- Sonio
- Tempus
- ThinkSono
- UltraSight
- Ultrasound AI
- Ultromics
- United Imaging
- Us2.ai
- Vave Health
- Viz.ai

